Elizabeth Half - Concepedia

Author

Elizabeth Half

Also Known As

E HALF, E Half, E. Half, E.E. Half, Elizabeth E Half, Elizabeth E. Half, Elizabeth Emily Half, Elizabeth Half, Half, Elizabeth E., K Monahan

112

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Rambam Health Care Campus The University of Texas MD Anderson Cancer Center Tel Aviv University Hadassah Medical Center Rabin Medical Center

About

Elizabeth Half is an author at Rambam Health Care Campus specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.3K
2	Public Health	2	2	239
3	Health Sciences	1	1	12
4	Biomedical Engineering	1	1	12
5	Biostatistics	1	1	127

Elizabeth Half

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Elizabeth Half, Xi Tang, Karin Gwyn, PubMed Breast OncologyCox-2 GenePathologyCox-2 ExpressionCancer Biology	2002	354
Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Yunjie Sun, Xi Tang, Elizabeth Half, PubMed Chemoprevention StrategyApoptosisCell DeathPathologyCox-2 Expression	2002	215
Gastric microbiota is altered in oesophagitis and <scp>B</scp> arrett's oesophagus and further modified by proton pump inhibitors Itay Amir, Fred M. Konikoff, Michal Oppenheim, Environmental Microbiology	2013	176
Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure Hadar Spivak, Mary F. Hewitt, Amir Onn, The American Journal of Surgery ObesityBariatric SurgeryObesity-related IllnessSleeve GastrectomyWeight Loss	2005	171
Fecal microbiome signatures of pancreatic cancer patients Elizabeth Half, Nirit Keren, Leah Reshef, Scientific Reports DysbiosisPancreatic CancerHealthy SubjectsMedicineGut Microbiology	2019	127
Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Ximing Tang, Yun Jie Sun, Elizabeth Half, PubMed Chemoprevention StrategyApoptosisImmunologyCell DeathPathology	2002	119
Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study Yaron Kinar, Nir Kalkstein, Pinchas Akiva, Journal of the American Medical Informatics Association	2016	118
Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study Aung Ko Win, James G. Dowty, Jeanette C. Reece, The Lancet Oncology Lynch SyndromeRetrospective Cohort StudyCancer RiskCancer EpidemiologyMedicine	2021	112
Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals Kasper A. Overbeek, Michael Goggins, Mohamad Dbouk, Gastroenterology	2021	106
An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis Patrick M. Lynch, Carol A. Burke, Robin Phillips, Gut	2015	101

Page 1